- Home
- GLSTU vs MREO Comparison
GLSTU vs MREO Comparison
Compare GLSTU & MREO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GLSTU
- MREO
- Stock Information
- Founded
- GLSTU N/A
- MREO 2015
- Country
- GLSTU
- MREO United Kingdom
- Employees
- GLSTU N/A
- MREO N/A
- Industry
- GLSTU
- MREO Biotechnology: Pharmaceutical Preparations
- Sector
- GLSTU
- MREO Health Care
- Exchange
- GLSTU NYSE
- MREO Nasdaq
- Market Cap
- GLSTU N/A
- MREO 451.5M
- IPO Year
- GLSTU N/A
- MREO N/A
- Fundamental
- Price
- GLSTU $12.05
- MREO $3.16
- Analyst Decision
- GLSTU
- MREO Strong Buy
- Analyst Count
- GLSTU 0
- MREO 6
- Target Price
- GLSTU N/A
- MREO $7.83
- AVG Volume (30 Days)
- GLSTU N/A
- MREO 1.3M
- Earning Date
- GLSTU N/A
- MREO 03-26-2025
- Dividend Yield
- GLSTU N/A
- MREO N/A
- EPS Growth
- GLSTU N/A
- MREO N/A
- EPS
- GLSTU N/A
- MREO N/A
- Revenue
- GLSTU N/A
- MREO $1,000,000.00
- Revenue This Year
- GLSTU N/A
- MREO N/A
- Revenue Next Year
- GLSTU N/A
- MREO $54.47
- P/E Ratio
- GLSTU N/A
- MREO N/A
- Revenue Growth
- GLSTU N/A
- MREO N/A
- 52 Week Low
- GLSTU N/A
- MREO $2.53
- 52 Week High
- GLSTU N/A
- MREO $5.02
- Technical
- Relative Strength Index (RSI)
- GLSTU 47.49
- MREO 48.76
- Support Level
- GLSTU $10.09
- MREO $2.85
- Resistance Level
- GLSTU $14.90
- MREO $3.06
- Average True Range (ATR)
- GLSTU 1.16
- MREO 0.18
- MACD
- GLSTU -0.04
- MREO 0.02
- Stochastic Oscillator
- GLSTU 40.75
- MREO 96.00
About GLSTU GLOBAL STAR ACQUISITION INC
Global Star Acquisition Inc is a blank check company.
About MREO Mereo BioPharma Group plc
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of innovative therapeutics for rare diseases. The Company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).